GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $431,000 | +1.2% | 9,898 | +1.1% | 0.02% | +14.3% |
| Q1 2022 | $426,000 | -1.4% | 9,787 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $432,000 | +15.5% | 9,787 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $374,000 | -5.1% | 9,787 | -1.0% | 0.01% | -6.7% |
| Q2 2021 | $394,000 | -29.6% | 9,887 | -37.0% | 0.02% | -37.5% |
| Q1 2021 | $560,000 | +53.8% | 15,687 | +58.7% | 0.02% | +41.2% |
| Q4 2020 | $364,000 | -2.9% | 9,887 | -0.7% | 0.02% | -10.5% |
| Q3 2020 | $375,000 | -13.4% | 9,960 | -6.1% | 0.02% | -24.0% |
| Q2 2020 | $433,000 | +7.7% | 10,608 | 0.0% | 0.02% | -10.7% |
| Q1 2020 | $402,000 | -17.1% | 10,608 | +2.7% | 0.03% | +3.7% |
| Q4 2019 | $485,000 | +7.5% | 10,325 | -2.3% | 0.03% | 0.0% |
| Q3 2019 | $451,000 | +7.9% | 10,570 | +1.2% | 0.03% | +3.8% |
| Q2 2019 | $418,000 | -3.2% | 10,444 | +1.2% | 0.03% | -7.1% |
| Q1 2019 | $432,000 | +6.1% | 10,325 | -3.2% | 0.03% | -6.7% |
| Q4 2018 | $407,000 | -1.7% | 10,670 | +3.5% | 0.03% | +15.4% |
| Q3 2018 | $414,000 | +9.2% | 10,305 | +9.6% | 0.03% | -7.1% |
| Q2 2018 | $379,000 | -62.3% | 9,406 | -63.4% | 0.03% | -59.4% |
| Q1 2018 | $1,004,000 | +14.0% | 25,701 | +3.4% | 0.07% | +13.1% |
| Q4 2017 | $881,000 | -12.7% | 24,849 | 0.0% | 0.06% | -17.6% |
| Q3 2017 | $1,009,000 | -15.9% | 24,849 | -10.7% | 0.07% | -20.4% |
| Q2 2017 | $1,200,000 | +1.4% | 27,822 | -0.9% | 0.09% | 0.0% |
| Q1 2017 | $1,183,000 | +9.4% | 28,071 | 0.0% | 0.09% | +3.3% |
| Q4 2016 | $1,081,000 | +114.5% | 28,071 | +124.6% | 0.09% | +73.1% |
| Q4 2015 | $504,000 | -6.5% | 12,498 | -0.9% | 0.05% | -8.8% |
| Q4 2014 | $539,000 | -35.5% | 12,611 | -19.4% | 0.06% | -40.6% |
| Q4 2013 | $836,000 | +33.5% | 15,651 | +8.6% | 0.10% | +3.2% |
| Q4 2012 | $626,000 | -0.8% | 14,409 | +4.3% | 0.09% | -13.1% |
| Q4 2011 | $631,000 | +20.2% | 13,819 | +3.2% | 0.11% | +17.6% |
| Q4 2010 | $525,000 | -14.4% | 13,389 | -7.7% | 0.09% | -22.9% |
| Q4 2009 | $613,000 | +17.7% | 14,509 | +4.0% | 0.12% | -6.3% |
| Q4 2008 | $521,000 | – | 13,956 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |